Holmusk is a digital solutions company with best-in-class real-world evidence and expertise in behavioral health. They have built the field's largest, most robust clinical database for real-world data and a uniquely powerful evidence engine to revolutionize the behavioral health landscape.

Holmusk

Holmusk is a data analytics and health technology company on a mission to harness real-world evidence to transform both research and care for behavioral health. 

Combining a leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation. Holmusk’s core offerings include HolCare EHR+, an electronic health records platform with built-in measurement-based care, and NeuroBlu Research, a powerful data analytics solution that enables users to build patient cohorts, explore datasets, and discover new insights. 

Founded in 2015, Holmusk is a global company headquartered in Singapore and New York. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum.

Veradigm

Capikris Foundation

Heritas Capital

Health Catalyst Capital

Optum Ventures

Northwell Ventures

Novartis

Unstructured EHR data in clinical notes is a rich source of clinical information and can be used alongside structured data to offer deeper patient characterization.

Holmusk has developed novel natural language processing (NLP) models specific to behavioral health to extract essential information from unstructured notes. These NLP models are applied to unstructured data, and the resulting insights are made available in NeuroBlu, a powerful analytics tool built to explore the world's richest real-world database for behavioral health.

Read the use case to learn more about how our newest NeuroBlu NLP model substantially increases cohort sizes when applied to unstructured notes for patients diagnosed with a psychotic disorder: https://hubs.li/Q02lTffV0

#RWD #realworlddata #NLP

The landscape of mental health research is evolving, and tools like Natural Language Processing (NLP) hold immense potential to bridge the gap between clinical trials and real-world evidence.

Our latest blog explores how we developed NeuroBlu NLP - novel NLP models designed to extract disease-specific features from unstructured clinical notes. These NLP-derived clinical features are then integrated into our structured data and made available in NeuroBlu, Holmusk’s powerful real-world data analytics software for behavioral health. 

Read the blog to learn more about the complexities of model development and how granular symptomatology data can be captured through the application of novel, fit-for-purpose NLP models: https://hubs.li/Q02lGn_t0

#RWD #realworlddata #NLP


Announcing NeuroBlu v3.8, the first release of 2024! 

This version of NeuroBlu integrates a suite of comprehensive data features and our new NeuroBlu NLP psychotic disorders model for in-depth research across our extensive patient database. NeuroBlu v3.8 is at the forefront of mental health data analysis with enhanced processing speeds and a strategic dataset management update.

Interested in learning more about the largest NLP-enriched, real-world data platform designed for behavioral and mental health? 

Read the release announcement here: https://hubs.li/Q02l72N70

#RWD #realworlddata #NLP

COM:HOLMUSK

Holmusk

locale

market

industry

website

crunchbase

linkedin

founding date

peer of

investor of

competitor of

Metrics